APA (7th ed.) Citation

Kawaguchi, N., Katsube, T., Echols, R., & Wajima, T. (2021). Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection. Antimicrobial agents and chemotherapy, 65(3), . https://doi.org/10.1128/AAC.01437-20

Chicago Style (17th ed.) Citation

Kawaguchi, Nao, Takayuki Katsube, Roger Echols, and Toshihiro Wajima. "Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection." Antimicrobial Agents and Chemotherapy 65, no. 3 (2021). https://doi.org/10.1128/AAC.01437-20.

MLA (9th ed.) Citation

Kawaguchi, Nao, et al. "Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection." Antimicrobial Agents and Chemotherapy, vol. 65, no. 3, 2021, https://doi.org/10.1128/AAC.01437-20.